BCAL Diagnostics Ltd

BCAL Diagnostics Limited is an Australia-based biotechnology company. The Company develops early, non-invasive blood test-based diagnostic technologies designed to complement mammograms and improve breast cancer screening outcomes. Its commercial laboratory, equipped with Liquid Chromatography Mass Spectrometry (LCMS) technology, is focused on scientific innovation and clinical service delivery, supporting both ongoing research and the commercial rollout of our diagnostic test. The Company develops a blood test for breast cancer screening and diagnosis. The assay measures a panel of lipids in blood plasma using Liquid Chromatography Tandem Mass Spectrometry (LC-MS/MS). Its lipid measurements are converted to a test score using a proprietary diagnostic algorithm. It offers BREASTEST plus, which is a blood test designed to be used alongside a mammogram in breast cancer screening. It provides information for women with dense breasts to help rule out the presence of breast cancer.